Jump to content
  • Sign Up

Archived

This topic is now archived and is closed to further replies.

Scott Adams

Abbvie's Latest Drug Deal Marks A Shift In The Celiac Disease Therapeutics Field - Seeking Alpha

Recommended Posts

AbbVie's Latest Drug Deal Marks A Shift In The Celiac Disease Therapeutics Field

Seeking Alpha

Compared to its relative prevalence, Celiac disease is the most common disease that has zero treatments on the market. To make matters worse, only four companies are developing drugs for treatment of Celiac, and until a few days ago, this entire field ...

View the full article

Share this post


Link to post
Share on other sites

 

 

AbbVie's Latest Drug Deal Marks A Shift In The Celiac Disease Therapeutics Field

Seeking Alpha

Compared to its relative prevalence, Celiac disease is the most common disease that has zero treatments on the market. To make matters worse, only four companies are developing drugs for treatment of Celiac, and until a few days ago, this entire field ...

 

                           

View the full article

 

wont let me read second page, without registering.

Share this post


Link to post
Share on other sites

×
×
  • Create New...